<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1860">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05136950</url>
  </required_header>
  <id_info>
    <org_study_id>2021KYPJ135</org_study_id>
    <nct_id>NCT05136950</nct_id>
  </id_info>
  <brief_title>Incidence of Glaucoma-related Adverse Events in Pediatric Secondary Intraocular Lens Implantation</brief_title>
  <official_title>Incidence of Glaucoma-related Adverse Events in Pediatric Secondary Intraocular Lens Implantation, In-the-bag Versus Sulcus Fixation : a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhongshan Ophthalmic Center, Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zhongshan Ophthalmic Center, Sun Yat-sen University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the incidence of glaucoma-related adverse events of in-the-bag versus&#xD;
      ciliary-sulcus-fixed secondary intraocular lens (IOL) implantation in pediatric aphakia&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Treatment of pediatric cataract, one of the leading causes of childhood blindness globally,&#xD;
      remains challenging because of extremely high incidence of glaucoma-related adverse events&#xD;
      (AEs) after IOL implantation. The investigators aim to compare the incidence of&#xD;
      glaucoma-related AEs of in-the-bag versus ciliary-sulcus-fixed secondary intraocular lens&#xD;
      (IOL) implantation in pediatric aphakia.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2022</start_date>
  <completion_date type="Anticipated">July 30, 2033</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of glaucoma-related adverse events</measure>
    <time_frame>One year after surgery</time_frame>
    <description>The assessment of glaucoma-related adverse events is performed at one year after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of glaucoma-related adverse events</measure>
    <time_frame>Six months,three years, five years, ten years after surgery</time_frame>
    <description>The assessment of glaucoma-related AEs is performed at six months, three years, five years, ten years after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>Six months,one year, three years, five years, ten years after surgery</time_frame>
    <description>Evaluated with an ETDRS chart. For those who are unable to use ETDRS chart, visual acuity will be evaluated with Lea Symbol Chart or Teller Acuity Cards</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ocular refractive power</measure>
    <time_frame>Six months,one year,three years, five years, ten years after surgery</time_frame>
    <description>Measured by the Auto Refractometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraocular lens decentration</measure>
    <time_frame>Six months,one year, three years, five years, ten years after surgery</time_frame>
    <description>Measured by anterior segment scanning</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraocular lens tilt</measure>
    <time_frame>Six months,one year, three years, five years, ten years after surgery</time_frame>
    <description>Measured by anterior segment scanning</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of other adverse events</measure>
    <time_frame>Six months,one year, three years, five years, ten years after surgery</time_frame>
    <description>The assessment of other adverse events will be performed at six months,one year,three years, five years, ten years after surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">228</enrollment>
  <condition>Lens Implantation, Intraocular</condition>
  <arm_group>
    <arm_group_label>Secondary in-the-bag IOL fixation group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In-the-bag IOL fixation is the experimental arm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Secondary ciliary sulcus IOL fixation group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ciliary sulcus IOL fixation is the control arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Secondary in-the-bag IOL fixation</intervention_name>
    <description>The experimental group with secondary IOL fixated in the capsular bag</description>
    <arm_group_label>Secondary in-the-bag IOL fixation group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Secondary ciliary sulcus IOL fixation</intervention_name>
    <description>The control group with secondary IOL fixated in the ciliary sulcus</description>
    <arm_group_label>Secondary ciliary sulcus IOL fixation group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged between 18 months and 14 years&#xD;
&#xD;
          -  Had a primary diagnosis of congenital cataract.&#xD;
&#xD;
          -  Underwent cataract extraction between the ages of 2 and 24 months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Primary IOL implantation&#xD;
&#xD;
          -  Pre-existing ocular disease which might affect the location and outcome of secondary&#xD;
             IOL implantation (including and not restricted to microphthalmia, microcornea,&#xD;
             microcornea, corneal opacity, pseudopterygium, iris anomaly, glaucoma diagnosed before&#xD;
             cataract extraction, uveitis, persistent fetal vasculature or trauma)&#xD;
&#xD;
          -  Suture fixation for secondary IOL implantation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Months</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yizhi Liu, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhongshan Ophthalmic center, Guangzhou, People's Republic of China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zhenzhen Liu, PhD</last_name>
    <phone>+86 13570382241</phone>
    <email>liu_zhenzhen@qq.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Zhongshan Ophthalmic Center, Sun Yat-sen University Guangzhou, China, 510060</name>
      <address>
        <city>Guangzhou</city>
        <zip>510060</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Liu Z, Lin H, Jin G, Tan X, Qu B, Jin L, Chen X, Wang W, Han X, Xu J, Ying G, Han Y, He M, Congdon N, Chen W, Luo L, Liu Y. In-the-bag versus Ciliary Sulcus Secondary Intraocular Lens Implantation for Pediatric Aphakia:A Prospective Comparative Study: Secondary Intraocular Lens Implantation for Children. Am J Ophthalmol. 2021 Oct 12. pii: S0002-9394(21)00522-5. doi: 10.1016/j.ajo.2021.10.006. [Epub ahead of print]</citation>
    <PMID>34653355</PMID>
  </results_reference>
  <results_reference>
    <citation>Wood KS, Tadros D, Trivedi RH, Wilson ME. Secondary intraocular lens implantation following infantile cataract surgery: intraoperative indications, postoperative outcomes. Eye (Lond). 2016 Sep;30(9):1182-6. doi: 10.1038/eye.2016.131. Epub 2016 Jul 1.</citation>
    <PMID>27367747</PMID>
  </results_reference>
  <results_reference>
    <citation>Freedman SF, Beck AD, Nizam A, Vanderveen DK, Plager DA, Morrison DG, Drews-Botsch CD, Lambert SR; Infant Aphakia Treatment Study Group. Glaucoma-Related Adverse Events at 10 Years in the Infant Aphakia Treatment Study: A Secondary Analysis of a Randomized Clinical Trial. JAMA Ophthalmol. 2021 Feb 1;139(2):165-173. doi: 10.1001/jamaophthalmol.2020.5664.</citation>
    <PMID>33331850</PMID>
  </results_reference>
  <results_reference>
    <citation>Shenoy BH, Mittal V, Gupta A, Sachdeva V, Kekunnaya R. Complications and visual outcomes after secondary intraocular lens implantation in children. Am J Ophthalmol. 2015 Apr;159(4):720-6. doi: 10.1016/j.ajo.2015.01.002. Epub 2015 Jan 9.</citation>
    <PMID>25579641</PMID>
  </results_reference>
  <results_reference>
    <citation>Zhao YE, Gong XH, Zhu XN, Li HM, Tu MJ, Coursey TG, Pflugfelder SC, Gu F, Chen D. Long-term outcomes of ciliary sulcus versus capsular bag fixation of intraocular lenses in children: An ultrasound biomicroscopy study. PLoS One. 2017 Mar 16;12(3):e0172979. doi: 10.1371/journal.pone.0172979. eCollection 2017.</citation>
    <PMID>28301497</PMID>
  </results_reference>
  <results_reference>
    <citation>Whitman MC, Vanderveen DK. Complications of pediatric cataract surgery. Semin Ophthalmol. 2014 Sep-Nov;29(5-6):414-20. doi: 10.3109/08820538.2014.959192. Review.</citation>
    <PMID>25325868</PMID>
  </results_reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 1, 2021</study_first_submitted>
  <study_first_submitted_qc>November 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 30, 2021</study_first_posted>
  <last_update_submitted>November 15, 2021</last_update_submitted>
  <last_update_submitted_qc>November 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pediatric aphakia</keyword>
  <keyword>Secondary Intraocular Lens Implantation</keyword>
  <keyword>Glaucoma-related Adverse Events</keyword>
  <keyword>In-the-bag IOL implantation</keyword>
  <keyword>Sulcus IOL fixation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

